Irisys Inc
- View government funding actions
- San Diego, CA 921213262
- Phone: 858-623-1520
- Corporate URL: www.irisys.com
- Estimated Number of Employees: 14
- Estimated Annual Receipts: $1,332,985
- Business Start Date: 1996
- Contact Person: Kevin Xie
- Contact Phone: 858-623-1520
- Contact Email: kxie@irisys.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Subchapter S Corporation
- Industries Served:
- Product Areas: R&D- DEFENSE OTHER: SERVICES (MANAGEMENT/SUPPORT), SERVICES (MANAGEMENT/SUPPORT), R&D- DEFENSE OTHER: SUBSISTENCE (ADVANCED DEVELOPMENT), SUBSISTENCE (ADVANCED), R&D- ECONOMIC GROWTH: PRODUCT/SERVICE IMPROVEMENT (ADVANCED DEVELOPMENT), R&D-PROD/SERV IMPROVEMENT-ADV DEV, R&D- ECONOMIC GROWTH: PRODUCT/SERVICE IMPROVEMENT (MANAGEMENT/SUPPORT), R&D-PROD/SERV IMPROVEMENT-MGMT SUP, R&D-OTHER SCIENCES-A RES/EXPL DEV, R&D- GENERAL SCIENCE/TECHNOLOGY: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), BIOMEDICAL (ADVANCED), R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT), R&D- MEDICAL: BIOMEDICAL (OPERATIONAL SYSTEMS DEVELOPMENT), BIOMEDICAL (OPERATIONAL), R&D- MEDICAL: BIOMEDICAL (MANAGEMENT/SUPPORT), BIOMEDICAL (MANAGEMENT/SUPPORT)
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $76,000 - Tuesday the 10th of April 2012
National Institutes Of Health
NIH, NCI, OD OM OA OFC ACQUISITIONS
TAS::75 0849::TAS DEVELOPMENT AND MANUFACTURE OF ORAL AND TOOPICAL DOSAGE FORMS - $20,000 - Tuesday the 7th of August 2012
National Institutes Of Health
NIH, NCI, OD OM OA OFC ACQUISITIONS
TAS::75 0849::TAS DEVELOPMENT AND MANUFACTURE OF ORAL AND TOOPICAL DOSAGE FORMS - $110,000 - Monday the 9th of July 2012
National Institutes Of Health
NIH, NCI, OD OM OA OFC ACQUISITIONS
TAS::75 0849::TAS DEVELOPMENT AND MANUFACTURE OF ORAL AND TOOPICAL DOSAGE FORMS
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.